Research & Literature

Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.

Han F, Grimes DA, Li F, et al.

The International journal of neuroscience 2016; (126(5)):415-21 doi:10.3109/00207454.2015.1023436.

Implementation of an Integrative Holistic Healthcare Model for People Living with Parkinson's Disease.

Pretzer-Aboff I, Prettyman A

The Gerontologist 2015; (55 Suppl 1()):S146-53 doi:10.1093/geront/gnv004.

[Deep brain stimulation: past, present time and future].

Pollak P, Burkhard P, Vingerhoets F

Revue medicale suisse 2015; (11(472)):958-61.

Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.

Kadastik-Eerme L, Rosenthal M, Paju T, et al.

Health and quality of life outcomes 2015; (13()):83 doi:10.1186/s12955-015-0281-x.

Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?

Arnaldi D, De Carli F, Picco A, et al.

Neurobiology of aging 2015; (36(12)):3300-3305 doi:10.1016/j.neurobiolaging.2015.08.025.

MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Berg D, Stern M, et al.

Movement disorders : official journal of the Movement Disorder Society 2015; (30(12)):1591-601 doi:10.1002/mds.26424.

Dysphagia in Parkinson's Disease.

Suttrup I, Warnecke T

Dysphagia 2016; (31(1)):24-32 doi:10.1007/s00455-015-9671-9.

Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience.

Bohlega S, Abou Al-Shaar H, Alkhairallah T, et al.

European neurology 2015; (74(5-6)):227-36 doi:10.1159/000442151.

DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons.

Atlas D

CNS neuroscience & therapeutics 2016; (22(6)):461-7 doi:10.1111/cns.12518.

Functional connectivity alterations in the motor and fronto-parietal network relate to behavioral heterogeneity in Parkinson's disease.

Vervoort G, Alaerts K, Bengevoord A, et al.

Parkinsonism & related disorders 2016; (24()):48-55.

Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson's disease.

Virmani T, Tazan S, Mazzoni P, et al.

Journal of clinical movement disorders 2016; (3()):8 doi:10.1186/s40734-016-0036-9.

Non-Motor symptoms in Portuguese Parkinson's Disease patients: correlation and impact on Quality of Life and Activities of Daily Living.

Bugalho P, Lampreia T, Miguel R, et al.

Scientific reports 2016; (6()):32267 doi:10.1038/srep32267.

The Impact of Physical Activity on Non-Motor Symptoms in Parkinson's Disease: A Systematic Review.

Cusso ME, Donald KJ, Khoo TK

Frontiers in medicine 2016; (3()):35 doi:10.3389/fmed.2016.00035.

l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice.

Ueda S, Masukawa D, Koga M, Goshima Y

Journal of pharmacological sciences 2016; (132(1)):109-112 doi:10.1016/j.jphs.2016.08.005.

Importance of Rapid Eye Movement Sleep Behavior Disorder to the Primary Care Physician.

McCarter SJ, Howell MJ

Mayo Clinic proceedings 2016; (91(10)):1460-1466 doi:10.1016/j.mayocp.2016.07.019.

Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson's disease and chronic constipation.

Su A, Gandhy R, Barlow C, Triadafilopoulos G

BMJ open gastroenterology 2016; (3(1)):e000118 doi:10.1136/bmjgast-2016-000118.

Deep brain stimulation for Parkinson's disease prior to L-dopa treatment: A case report.

Servello D, Saleh C, Bona AR, et al.

Surgical neurology international 2016; (7(Suppl 35)):S827-S829 doi:10.4103/2152-7806.194064.

[No motor signs in Parkinson's disease].

Azulay JP, Witjas T, Eusebio A

Presse medicale (Paris, France : 1983) 2017; (46(2 Pt 1)):195-201 doi:10.1016/j.lpm.2016.11.015.

Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging.

Premi E, Calhoun VD, Garibotto V, et al.

Molecular imaging and biology 2017; (19(5)):772-778 doi:10.1007/s11307-017-1052-3.

A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned.

Parkinsonism & related disorders 2017; (37()):101-105 doi:10.1016/j.parkreldis.2017.02.003.

Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.

Domellöf ME, Lundin KF, Edström M, Forsgren L

Parkinsonism & related disorders 2017; (38()):41-47 doi:10.1016/j.parkreldis.2017.02.017.

Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder.

McKenna D, Peever J

Movement disorders : official journal of the Movement Disorder Society 2017; (32(5)):636-644 doi:10.1002/mds.27003.

REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.

St Louis EK, Boeve AR, Boeve BF

Movement disorders : official journal of the Movement Disorder Society 2017; (32(5)):645-658 doi:10.1002/mds.27018.

Protein-Restricted Diets for Ameliorating Motor Fluctuations in Parkinson's Disease.

Wang L, Xiong N, Huang J, et al.

Frontiers in aging neuroscience 2017; (9()):206 doi:10.3389/fnagi.2017.00206.

Response inhibition in Parkinson's disease: a meta-analysis of dopaminergic medication and disease duration effects.

Manza P, Amandola M, Tatineni V, et al.

NPJ Parkinson's disease 2017; (3()):23 doi:10.1038/s41531-017-0024-2.

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Erkkinen MG, Kim MO, Geschwind MD

Cold Spring Harbor perspectives in biology 2018; (10(4)) doi:10.1101/cshperspect.a033118.

Progression marker of Parkinson's disease: a 4-year multi-site imaging study.

Burciu RG, Ofori E, Archer DB, et al.

Brain : a journal of neurology 2017; (140(8)):2183-2192 doi:10.1093/brain/awx146.

Deep brain stimulation: foundations and future trends.

Aum DJ, Tierney TS

Frontiers in bioscience (Landmark edition) 2018; (23(1)):162-182 doi:10.2741/4586.

Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis.

McDonnell MN, Rischbieth B, Schammer TT, et al.

Clinical rehabilitation 2018; (32(5)):607-618 doi:10.1177/0269215517734385.

Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson's disease.

Maekawa T, Sato N, Ota M, et al.

Japanese journal of radiology 2017; (35(12)):755-759 doi:10.1007/s11604-017-0694-z.

Sleep disturbances in Taiwanese patients with Parkinson's disease.

Lin YY, Chen RS, Lu CS, et al.

Brain and behavior 2017; (7(10)):e00806 doi:10.1002/brb3.806.

Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease.

Ten Harmsen BL, van Rumund A, Aerts MB, et al.

Parkinsonism & related disorders 2018; (49()):28-33 doi:10.1016/j.parkreldis.2017.12.029.

Nanocarrier for levodopa Parkinson therapeutic drug; comprehensive benserazide analysis.

Yoosefian M, Rahmanifar E, Etminan N

Artificial cells, nanomedicine, and biotechnology 2018; (46(sup1)):434-446 doi:10.1080/21691401.2018.1430583.

Tremor: Sorting Through the Differential Diagnosis.

Crawford P, Zimmerman EE

American family physician 2018; (97(3)):180-186.

[New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria].

Watanabe H, Hara K, Ito M, et al.

Brain and nerve = Shinkei kenkyu no shinpo 2018; (70(2)):139-146 doi:10.11477/mf.1416200966.

Animal models of l-dopa-induced dyskinesia in Parkinson's disease.

Cenci MA, Crossman AR

Movement disorders : official journal of the Movement Disorder Society 2018; (33(6)):889-899 doi:10.1002/mds.27337.

Selegiline increases on time without exacerbation of dyskinesia in 6-hydroxydopamine-lesioned rats displaying l-Dopa-induced wearing-off and abnormal involuntary movements.

Tsunekawa H, Takahata K, Okano M, et al.

Behavioural brain research 2018; (347()):350-359 doi:10.1016/j.bbr.2018.03.002.

GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Gan-Or Z, Liong C, Alcalay RN

Current neurology and neuroscience reports 2018; (18(8)):44 doi:10.1007/s11910-018-0860-4.

LRRK2 and mitochondria: Recent advances and current views.

Singh A, Zhi L, Zhang H

Brain research 2019; (1702()):96-104 doi:10.1016/j.brainres.2018.06.010.

Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.

Tran TN, Vo TNN, Frei K, Truong DD

Journal of neural transmission (Vienna, Austria : 1996) 2018; (125(8)):1109-1117 doi:10.1007/s00702-018-1900-6.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Poewe W, Litvan I, et al.

Movement disorders : official journal of the Movement Disorder Society 2018; (33(10)):1601-1608 doi:10.1002/mds.27362.

[Deep brain stimulation in Parkinson's disease].

Kunstmann C, Valdivia F, De Marinis A, et al.

Revista medica de Chile 2018; (146(5)):562-569 doi:10.4067/s0034-98872018000500562.

Non-motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life.

Huang X, Ng SY, Chia NS, et al.

European journal of neurology 2019; (26(3)):400-406 doi:10.1111/ene.13803.

Handwriting Analysis in Parkinson's Disease: Current Status and Future Directions.

Thomas M, Lenka A, Kumar Pal P

Movement disorders clinical practice 2017; (4(6)):806-818 doi:10.1002/mdc3.12552.

Limb Kinetic Apraxia Is an Independent Predictor for Quality of Life in Parkinson's Disease.

Vanbellingen T, Hofmänner D, Kübel S, Bohlhalter S

Movement disorders clinical practice 2018; (5(2)):156-159 doi:10.1002/mdc3.12572.

Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review.

Yeung EYH, Cavanna AE

Movement disorders clinical practice 2014; (1(4)):307-316 doi:10.1002/mdc3.12063.

Evaluation of dysphagia in different phenotypes of early and idiopathic Parkinsonism.

Mohamed AB, Mohamed GF, Elnady HM, et al.

The Egyptian journal of neurology, psychiatry and neurosurgery 2018; (54(1)):28 doi:10.1186/s41983-018-0031-1.

BDNF provides many routes toward STN DBS-mediated disease modification.

Fischer DL, Sortwell CE

Movement disorders : official journal of the Movement Disorder Society 2019; (34(1)):22-34 doi:10.1002/mds.27535.

Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson's disease.

Stocchi F, Vacca L, Stirpe P, Torti M

Expert opinion on drug metabolism & toxicology 2018; (14(12)):1189-1195 doi:10.1080/17425255.2018.1550483.

Multidisciplinary care for people with Parkinson's disease: the new kids on the block!

Radder DLM, de Vries NM, Riksen NP, et al.

Expert review of neurotherapeutics 2019; (19(2)):145-157 doi:10.1080/14737175.2019.1561285.

Impulse Control Disorders and Dopamine-Related Creativity: Pathogenesis and Mechanism, Short Review, and Hypothesis.

Garcia-Ruiz PJ

Frontiers in neurology 2018; (9()):1041 doi:10.3389/fneur.2018.01041.

Magnetic Resonance-Guided Focused Ultrasound: A Brief Review With Emphasis on the Treatment of Extra-abdominal Desmoid Tumors.

Griffin MO, Kulkarni NM, OʼConnor SD, et al.

Ultrasound quarterly 2019; (35(4)):346-354 doi:10.1097/RUQ.0000000000000431.

Long-term outcomes of deep brain stimulation in severe Parkinson's disease utilizing UPDRS III and modified Hoehn and Yahr as a severity scale.

Kahn L, Mathkour M, Lee SX, et al.

Clinical neurology and neurosurgery 2019; (179()):67-73 doi:10.1016/j.clineuro.2019.02.018.

Should non-movement specialists refer patients for SPECT-DaTSCAN?

Gajos A, Dąbrowski J, Bieńkiewicz M, et al.

Neurologia i neurochirurgia polska 2019; (53(2)):138-143 doi:10.5603/PJNNS.a2019.0011.

Dysphagia predicts poor outcome in late-stage Parkinson's disease.

Fabbri M, Coelho M, Abreu D, et al.

Parkinsonism & related disorders 2019; (64()):73-81 doi:10.1016/j.parkreldis.2019.02.043.

Predictors of health-related quality of life in Parkinson's disease.

Kuhlman GD, Flanigan JL, Sperling SA, Barrett MJ

Parkinsonism & related disorders 2019; (65()):86-90 doi:10.1016/j.parkreldis.2019.05.009.

Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review.

Biswas D, Karabin B, Turner D

International journal of general medicine 2019; (12()):173-184 doi:10.2147/IJGM.S170655.

Parkinsonism in essential tremor cases: A clinicopathological study.

Rajput AH, Rajput EF, Bocking SM, et al.

Movement disorders : official journal of the Movement Disorder Society 2019; (34(7)):1031-1040 doi:10.1002/mds.27729.

Deep Brain Stimulation in Parkinson's Disease.

Malek N

Neurology India 2019; (67(4)):968-978 doi:10.4103/0028-3886.266268.

A Study for Therapeutic Treatment against Parkinson's Disease via Chou's 5-steps Rule.

Lan J, Liu Z, Liao C, et al.

Current topics in medicinal chemistry 2019; (19(25)):2318-2333 doi:10.2174/1568026619666191019111528.

[The applicability of 123I-FP-CIT SPECT dopamine transporter imaging in clinical practice].

Perlaki G, Szekeres S, Janszky J, et al.

Ideggyogyaszati szemle 2019; (72(11-12)):381-388 doi:10.18071/isz.72.0381.

Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.

Jin W

Journal of clinical medicine 2020; (9(1)) doi:10.3390/jcm9010257.

Biomechanical analysis of sit-to-walk in different Parkinson's disease subtypes.

Pelicioni PHS, Pereira MP, Lahr J, et al.

Clinical biomechanics (Bristol, Avon) 2020; (75()):105010 doi:10.1016/j.clinbiomech.2020.105010.

Perception of Healthcare Access and Utility of Telehealth Among Parkinson's Disease Patients.

Peacock D, Baumeister P, Monaghan A, et al.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2020; (47(5)):700-704 doi:10.1017/cjn.2020.99.

Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls.

LeWitt PA, Kymes S, Hauser RA

Aging and disease 2020; (11(3)):679-691 doi:10.14336/AD.2019.0805.

Patient-Centric Care for Parkinson's Disease: From Hospital to the Community.

Aye YM, Liew S, Neo SX, et al.

Frontiers in neurology 2020; (11()):502 doi:10.3389/fneur.2020.00502.

Prevalence of Non-motor Symptoms in Parkinson's Disease and Its Impact on Quality of Life in Tertiary Care Center in India.

Karri M, Ramasamy B, Kalidoss R

Annals of Indian Academy of Neurology 2020; (23(3)):270-274 doi:10.4103/aian.AIAN_10_19.

Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson's disease: a systematic review and meta-analysis.

Xu Y, Yang B, Zhou C, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(1)):267-274 doi:10.1007/s10072-020-04555-7.

Increased rapid eye movement density in Chinese patients with Parkinson's disease and RBD.

Zhu J, Lu L, Zhong M, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(3)):961-968 doi:10.1007/s10072-020-04597-x.

[Non-motor symptoms of Parkinson's disease from pathophysiology to early diagnosis].

Aubignat M, Tir M, Krystkowiak P

La Revue de medecine interne 2021; (42(4)):251-257 doi:10.1016/j.revmed.2020.06.019.

Medical Management and Prevention of Motor Complications in Parkinson's Disease.

Aradi SD, Hauser RA

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2020; (17(4)):1339-1365 doi:10.1007/s13311-020-00889-4.

Neurogenic Orthostatic Hypotension: State of the Art and Therapeutic Strategies.

Kalra DK, Raina A, Sohal S

Clinical Medicine Insights. Cardiology 2020; (14()):1179546820953415 doi:10.1177/1179546820953415.

Is Levodopa Response a Valid Indicator of Parkinson's Disease?

Martin WRW, Miles M, Zhong Q, et al.

Movement disorders : official journal of the Movement Disorder Society 2021; (36(4)):948-954 doi:10.1002/mds.28406.

[Deep brain stimulation for Parkinson's disease].

Nikolov P, Groiss SJ, Schnitzler A

Fortschritte der Neurologie-Psychiatrie 2021; (89(1-02)):56-65 doi:10.1055/a-1260-0401.

Clinical value of machine learning-based interpretation of I-123 FP-CIT scans to detect Parkinson's disease: a two-center study.

Dotinga M, van Dijk JD, Vendel BN, et al.

Annals of nuclear medicine 2021; (35(3)):378-385 doi:10.1007/s12149-021-01576-w.

Gastrointestinal dysfunction in movement disorders.

Sakakibara R

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(4)):1355-1365 doi:10.1007/s10072-021-05041-4.

Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods.

Kaiserova M, Grambalova Z, Kurcova S, et al.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2021; (165(2)):103-112 doi:10.5507/bp.2021.002.

Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson's Disease.

Isaacson JR, Brillman S, Chhabria N, Isaacson SH

Journal of Parkinson's disease 2021; (11(2)):885-889 doi:10.3233/JPD-202506.

Sleep problems affect quality of life in Parkinson's disease along disease progression.

Liguori C, De Franco V, Cerroni R, et al.

Sleep medicine 2021; (81()):307-311 doi:10.1016/j.sleep.2021.02.036.

Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism.

Schindlbeck KA, Gupta DK, Tang CC, et al.

European journal of nuclear medicine and molecular imaging 2021; (48(11)):3522-3529 doi:10.1007/s00259-021-05302-6.

Longitudinal Study of Boxing Therapy in Parkinson's Disease, Including Adverse Impacts of the COVID-19 Lockdown.

Horbinski C, Zumpf KB, McCortney K, Eoannou D

Research square 2021; doi:10.21203/rs.3.rs-355283/v1.

Toward living neuroprosthetics: developing a biological brain pacemaker as a living neuromodulatory implant for improving parkinsonian symptoms.

Prox J, Seicol B, Qi H, et al.

Journal of neural engineering 2021; (18(4)) doi:10.1088/1741-2552/ac02dd.

Battery for deep brain stimulation depletion in Parkinson's Disease and dystonia patients - a systematic review.

Przytuła F, Dulski J, Sobstyl M, Sławek J

Neurologia i neurochirurgia polska 2021; (55(4)):346-350 doi:10.5603/PJNNS.a2021.0041.

Short-term effect and its retention of LSVT® BIG on QOL improvement: 1-year follow-up in a patient with Parkinson's disease.

Hirakawa Y, Koyama S, Takeda K, et al.

NeuroRehabilitation 2021; (49(3)):501-509 doi:10.3233/NRE-210129.

Increased Mortality in Young-Onset Parkinson's Disease.

Hustad E, Myklebust TÅ, Gulati S, Aasly JO

Journal of movement disorders 2021; (14(3)):214-220 doi:10.14802/jmd.21029.

New insights into pathogenesis of l-DOPA-induced dyskinesia.

Zheng C, Zhang F

Neurotoxicology 2021; (86()):104-113 doi:10.1016/j.neuro.2021.07.006.

Focused ultrasound for functional neurosurgery.

Lev-Tov L, Barbosa DAN, Ghanouni P, et al.

Journal of neuro-oncology 2022; (156(1)):17-22 doi:10.1007/s11060-021-03818-3.

The contribution of cognitive behavioural factors to social anxiety in Parkinson's disease.

Nash K, Dysch L, Todd Jones J, et al.

Behavioural and cognitive psychotherapy 2022; (50(1)):57-73 doi:10.1017/S1352465821000291.

Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline.

Arpin DJ, Mitchell T, Archer DB, et al.

Movement disorders : official journal of the Movement Disorder Society 2022; (37(2)):325-333 doi:10.1002/mds.28838.

[Essential Tremor That is Difficult to Improve with Standard Medical Treatment-Suppression: Surgical Treatment of Tremor].

Sasaki T, Date I

Brain and nerve = Shinkei kenkyu no shinpo 2022; (74(5)):645-651 doi:10.11477/mf.1416202092.

[Atypical Parkinson's syndrome in old age].

Iglseder B, Lange R

Zeitschrift fur Gerontologie und Geriatrie 2022; (55(5)):421-430 doi:10.1007/s00391-022-02077-9.

Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease.

Sampedro F, Martínez-Horta S, Horta-Barba A, et al.

European journal of neurology 2022; (29(12)):3720-3727 doi:10.1111/ene.15513.

Retrospective Multicenter Study on Outcome Measurement for Dyskinesia Improvement in Parkinson's Disease Patients with Pallidal and Subthalamic Nucleus Deep Brain Stimulation.

Meng F, Cen S, Yi Z, et al.

Brain sciences 2022; (12(8)) doi:10.3390/brainsci12081054.

Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China.

Wang S, Li T, Zhou T, et al.

BMC neurology 2022; (22(1)):367 doi:10.1186/s12883-022-02899-5.

Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study.

Fusaroli M, Giunchi V, Battini V, et al.

Psychiatry and clinical neurosciences 2023; (77(3)):160-167 doi:10.1111/pcn.13511.

Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?

Virameteekul S, Revesz T, Jaunmuktane Z, et al.

Movement disorders : official journal of the Movement Disorder Society 2023; (38(4)):558-566 doi:10.1002/mds.29317.

Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.

Ernst M, Folkerts AK, Gollan R, et al.

The Cochrane database of systematic reviews 2023; (1()):CD013856 doi:10.1002/14651858.CD013856.pub2.

The Impact of Nonmotor Symptoms on Health-Related Quality of Life in Parkinson's Disease: A Network Analysis Approach.

Heimrich KG, Schönenberg A, Santos-García D, et al.

Journal of clinical medicine 2023; (12(7)) doi:10.3390/jcm12072573.

Magnetic Resonance-Guided focused ultrasound surgery for Parkinson's disease: A mini-review and comparison between deep brain stimulation.

Ko TH, Lee YH, Chan L, et al.

Parkinsonism & related disorders 2023; (111()):105431 doi:10.1016/j.parkreldis.2023.105431.

Quantitative assessment of the gait improvement effect of LSVT BIG® using a wearable sensor in patients with Parkinson's disease.

Matsuno A, Matsushima A, Saito M, et al.

Heliyon 2023; (9(6)):e16952 doi:10.1016/j.heliyon.2023.e16952.

To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease.

Rusch C, Flanagan R, Suh H, Subramanian I

NPJ Parkinson's disease 2023; (9(1)):98 doi:10.1038/s41531-023-00541-w.

Caregiver burden in Parkinson's disease: a mixed-methods study.

Geerlings AD, Kapelle WM, Sederel CJ, et al.

BMC medicine 2023; (21(1)):247 doi:10.1186/s12916-023-02933-4.

Care access and utilization among medicare beneficiaries living with Parkinson's disease.

Pearson C, Hartzman A, Munevar D, et al.

NPJ Parkinson's disease 2023; (9(1)):108 doi:10.1038/s41531-023-00523-y.

Advances in non-pharmacological management of Parkinson's disease complicated with blood pressure abnormalities.

Xing Q, Zhao X, Xie L, et al.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2023; (74(4)) doi:10.26402/jpp.2023.4.01.

Rapid Eye Movement Sleep Behavior Disorder: Management and Prognostic Counseling.

Malkani R

Sleep medicine clinics 2024; (19(1)):83-92 doi:10.1016/j.jsmc.2023.12.001.

Effects and Mechanisms of Exercise on Brain-Derived Neurotrophic Factor (BDNF) Levels and Clinical Outcomes in People with Parkinson's Disease: A Systematic Review and Meta-Analysis.

Kaagman DGM, van Wegen EEH, Cignetti N, et al.

Brain sciences 2024; (14(3)) doi:10.3390/brainsci14030194.

Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management.

Carbone F, Djamshidian A

CNS drugs 2024; (38(6)):443-457 doi:10.1007/s40263-024-01087-y.

I123-FP-CIT (DaTSCAN) SPECT beyond the Most Common Causes of Parkinsonism: A Systematic Review.

Quintas S, Sanles-Falagan R, Berbís MÁ

Movement disorders clinical practice 2024; (11(6)):613-625 doi:10.1002/mdc3.14055.

Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson's Disease.

Braunger LJ, Knab F, Gasser T

Journal of Parkinson's disease 2024; (14(5)):977-991 doi:10.3233/JPD-230408.

An Ethnographic Study of Patient Life Experience in Early-Stage Parkinson's Disease in the United States and Germany.

Carmody T, Park R, Bennett E, et al.

Neurology and therapy 2024; (13(4)):1219-1235 doi:10.1007/s40120-024-00632-7.

Prevalence of Late-Stage Parkinson's Disease in the US Healthcare System: Insights from TriNetX.

De Jesus S, Daya A, Blumberger L, et al.

Movement disorders : official journal of the Movement Disorder Society 2024; (39(9)):1592-1601 doi:10.1002/mds.29900.

Comparative Efficacy of Deep Brain Stimulation to the Globus Pallidus Internus Versus the Subthalamic Nucleus in Parkinson's Disease.

Mingming S, Zhaohui Z, Lihong Q, et al.

Alternative therapies in health and medicine 2024;.

A Retrospective Analysis of Group-Based Boxing Exercise on Measures of Physical Mobility in Patients With Parkinson Disease.

Sonne JWH, Joslyn K, Reus K, et al.

American journal of lifestyle medicine 2024; (18(4)):558-566 doi:10.1177/15598276211028144.

Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes.

Houot M, Arnaud S, Mongin M, et al.

Scientific reports 2024; (14(1)):25088 doi:10.1038/s41598-024-73777-y.

Clinical features and progression of Parkinson's disease with LRRK2 variants: A prospective study.

Song T, Zhou X, Wang C, et al.

Annals of clinical and translational neurology 2025; (12(1)):34-42 doi:10.1002/acn3.52244.

An interdisciplinary approach to rehabilitation in Parkinson's disease: case series.

Lowell ER, Macpherson C, Villarreal-Cavazos K, et al.

Neurodegenerative disease management 2024; (14(6)):217-226 doi:10.1080/17582024.2024.2421736.

Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale.

Amstutz D, Sousa M, Maradan-Gachet ME, et al.

Revue neurologique 2025; (181(4)):265-283 doi:10.1016/j.neurol.2024.11.004.

Determination of High-Sensitivity C-reactive protein in Patient with Early Parkinson's disease.

Emran MM, Malik SS, Wahiduzzaman M, et al.

Mymensingh medical journal : MMJ 2025; (34(1)):159-165.

Effects of LSVT LOUD and EMST in individuals with Parkinson's disease: A two arm non-randomized clinical trial.

Saleem S, Miles A, Allen J

International journal of speech-language pathology 2025; 1-15 doi:10.1080/17549507.2025.2455635.

Neutrophil-to-Lymphocyte Ratio as a Biomarker for Motor Subtypes in Idiopathic Parkinson's Disease.

Awan R, Tahir O, Noor Ul Hadi S, et al.

Cureus 2025; (17(1)):e77440 doi:10.7759/cureus.77440.

Profile of Independence in Activities of Daily Living Among Patients With Parkinson's Disease: A Retrospective Observational Study.

Yokoi K, Kawasaki I, Takeda A, et al.

The American journal of occupational therapy : official publication of the American Occupational Therapy Association 2025; (79(3)) doi:10.5014/ajot.2025.050882.

High Intensity Focused Ultrasound - Longitudinal Data on Efficacy and Safety.

Thomas B, Bellini G, Lee WY, et al.

Tremor and other hyperkinetic movements (New York, N.Y.) 2025; (15()):18 doi:10.5334/tohm.987.

The role of L-DOPA in neurological and neurodegenerative complications: a review.

Kulkarni SR, Thokchom B, Abbigeri MB, et al.

Molecular and cellular biochemistry 2025; (480(10)):5221-5242 doi:10.1007/s11010-025-05324-w.

Efficacy and safety of oral amantadine in Parkinson's disease with dyskinesia and motor fluctuations: a systematic review and meta-analysis of randomised controlled trials.

Rujirussawarawong S, Aungsumart S, Kasemsuk C, Limotai N

BMJ neurology open 2025; (7(1)):e001115 doi:10.1136/bmjno-2025-001115.

G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.

Gaig C, Martí MJ, Ezquerra M, et al.

BMJ case reports 2025; (2009()) doi:10.1136/bcr.08.2008.0632.

Healthcare Complexities in Neurodegenerative Proteinopathies: A Narrative Review.

Fereshtehnejad SM, Lökk J

Healthcare (Basel, Switzerland) 2025; (13(15)) doi:10.3390/healthcare13151873.

Intersection of Autonomic Dysfunction and Parkinson's Disease: Insights Into Neurogenic and Classical Orthostatic Hypotension.

Pitton Rissardo J, Rashidi M, Rashidi F, et al.

Cureus 2025; (17(7)):e88487 doi:10.7759/cureus.88487.

The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson's Disease in Different World Regions.

García-Bustillo Á, Youn J, Ahn JH, et al.

Movement disorders clinical practice 2025; doi:10.1002/mdc3.70314.

[Trembling hands and more: when to suspect Parkinson's disease].

Steidel K, Pedrosa D

Deutsche medizinische Wochenschrift (1946) 2025; (150(18)):1069-1075 doi:10.1055/a-2514-0260.

Exercise as a multitarget therapy: modulating myokines, neurotrophins, and inflammation in Parkinson's disease.

Li WQ, Yang JH, Liu LL, et al.

Frontiers in aging neuroscience 2025; (17()):1580029 doi:10.3389/fnagi.2025.1580029.

A longitudinal study on physical activity in early Parkinson's disease.

Ng SY, Naheed D, Saffari ES, et al.

Journal of Parkinson's disease 2025; (15(8)):1524-1528 doi:10.1177/1877718X251380487.

Review of the Effects of Lifestyle Modification on Parkinson's Disease.

Baghaei A, Kim HS, Dolhun R, et al.

American journal of lifestyle medicine 2025; 15598276251384591 doi:10.1177/15598276251384591.

The role of motor subtypes in modulating neuropsychiatric and cognitive function in Parkinson's disease: A group-stratified mediation analysis.

Chien CY, Tan CH, Hong WP, et al.

Journal of psychiatric research 2026; (192()):352-359 doi:10.1016/j.jpsychires.2025.10.069.

[Hoehn & Yahr scale and MDS-UPDRS Part 3 progression in Parkinson's disease patients: retrospective natural history study using a disease registry].

Watanabe T, Naoi I, Obata R, et al.

Rinsho shinkeigaku = Clinical neurology 2025; (65(12)):865-872 doi:10.5692/clinicalneurol.cn-002132.

Factors impacting caregiver burden in Parkinson's disease: A systematic review and meta-analysis.

Sin WWF, Chan LML, Ng CTY, et al.

International journal of nursing studies 2025; (174()):105299 doi:10.1016/j.ijnurstu.2025.105299.

Development and Evaluation of a Speech-to-Noise Ratio Feedback System.

Wang L, Adams S, Parsa V

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2025; (2025()):1-6 doi:10.1109/EMBC58623.2025.11254250.

The Impact of Dance-Based Physical Activity on Sensorimotor and Psychological Function in Parkinson's Disease: A Narrative Review.

Carretti G, Guidi L, Manetti M, Marini M

Healthcare (Basel, Switzerland) 2026; (14(1)) doi:10.3390/healthcare14010105.

From Ablation to Neuromodulation Platform: The Evolving Role of Magnetic Resonance-Guided Focused Ultrasound in Functional Neurosurgery.

Lee S, Chang JW

Journal of clinical neurology (Seoul, Korea) 2026; (22(1)):17-41 doi:10.3988/jcn.2025.0563.